These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28800127)

  • 21. MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis.
    Nguyen HV; Vandenberg CJ; Robati MR; Ng AP; Cory S
    Cell Death Differ; 2023 Apr; 30(4):1018-1032. PubMed ID: 36755068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
    Si J; Yu X; Zhang Y; DeWille JW
    Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
    Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
    Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence of mnt-myc antagonism revealed by mnt gene deletion.
    Hurlin PJ; Zhou ZQ; Toyo-Oka K; Ota S; Walker WL; Hirotsune S; Wynshaw-Boris A
    Cell Cycle; 2004 Feb; 3(2):97-9. PubMed ID: 14712062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis.
    Nakamura I; Roberts LR
    Gastroenterology; 2011 Jul; 141(1):32-4. PubMed ID: 21620848
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
    Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
    Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Mathsyaraja H; Freie B; Cheng PF; Babaeva E; Catchpole JT; Janssens D; Henikoff S; Eisenman RN
    Genes Dev; 2019 Sep; 33(17-18):1252-1264. PubMed ID: 31395740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
    Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mnt takes control as key regulator of the myc/max/mxd network.
    Wahlström T; Henriksson M
    Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
    Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
    Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
    Yang H; Li TW; Peng J; Tang X; Ko KS; Xia M; Aller MA
    Gastroenterology; 2011 Jul; 141(1):378-88, 388.e1-4. PubMed ID: 21440549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
    Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
    Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.
    Farina A; Faiola F; Martinez E
    Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Mad side of the Max network: antagonizing the function of Myc and more.
    Rottmann S; Lüscher B
    Curr Top Microbiol Immunol; 2006; 302():63-122. PubMed ID: 16620026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
    Smith AG; Popov N; Imreh M; Axelson H; Henriksson M
    J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators.
    Sommer A; Bousset K; Kremmer E; Austen M; Lüscher B
    J Biol Chem; 1998 Mar; 273(12):6632-42. PubMed ID: 9506959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
    Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
    BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.